electroCore, Inc. (ECOR)
USD 5.64
(-4.0%)
USD 5.64
(-4.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.38 Million USD | -33.81% |
| 2022 | 24.75 Million USD | -42.2% |
| 2021 | 42.83 Million USD | 35.9% |
| 2020 | 31.51 Million USD | -12.69% |
| 2019 | 36.09 Million USD | -50.89% |
| 2018 | 73.5 Million USD | 87.35% |
| 2017 | 39.23 Million USD | 6207.34% |
| 2016 | 622.01 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 22.35 Million USD | 60.94% |
| 2024 Q1 | 13.89 Million USD | -15.24% |
| 2023 Q4 | 16.38 Million USD | -18.51% |
| 2023 Q1 | 18.3 Million USD | -26.08% |
| 2023 Q2 | 14.22 Million USD | -22.28% |
| 2023 FY | 16.38 Million USD | -33.81% |
| 2023 Q3 | 20.1 Million USD | 41.39% |
| 2022 Q2 | 33.48 Million USD | -9.95% |
| 2022 Q4 | 24.75 Million USD | -16.06% |
| 2022 FY | 24.75 Million USD | -42.2% |
| 2022 Q1 | 37.18 Million USD | -13.19% |
| 2022 Q3 | 29.49 Million USD | -11.92% |
| 2021 Q1 | 33.75 Million USD | 7.08% |
| 2021 FY | 42.83 Million USD | 35.9% |
| 2021 Q4 | 42.83 Million USD | -9.96% |
| 2021 Q3 | 47.57 Million USD | 52.0% |
| 2021 Q2 | 31.29 Million USD | -7.27% |
| 2020 Q4 | 31.51 Million USD | -14.99% |
| 2020 Q3 | 37.07 Million USD | 29.37% |
| 2020 FY | 31.51 Million USD | -12.69% |
| 2020 Q2 | 28.65 Million USD | 6.14% |
| 2020 Q1 | 26.99 Million USD | -25.2% |
| 2019 Q4 | 36.09 Million USD | -18.13% |
| 2019 Q3 | 44.09 Million USD | -12.78% |
| 2019 Q2 | 50.54 Million USD | -19.12% |
| 2019 FY | 36.09 Million USD | -50.89% |
| 2019 Q1 | 62.49 Million USD | -14.97% |
| 2018 Q3 | 85.42 Million USD | -14.7% |
| 2018 FY | 73.5 Million USD | 87.35% |
| 2018 Q1 | 31.27 Million USD | -20.28% |
| 2018 Q2 | 100.14 Million USD | 220.2% |
| 2018 Q4 | 73.5 Million USD | -13.95% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 39.23 Million USD | 0.0% |
| 2017 FY | 39.23 Million USD | 6207.34% |
| 2016 FY | 622.01 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 47.756% |
| BrainsWay Ltd. | 62.97 Million USD | 73.977% |
| Cerus Corporation | 197.74 Million USD | 91.713% |
| Envoy Medical, Inc. | 7.64 Million USD | -114.49% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -113.04% |
| IceCure Medical Ltd | 16.41 Million USD | 0.14% |
| Inogen, Inc. | 326.19 Million USD | 94.976% |
| OrthoPediatrics Corp. | 449.58 Million USD | 96.355% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 39.908% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 1.158% |
| MaxCyte, Inc. | 268.27 Million USD | 93.892% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -102.376% |
| Nexalin Technology, Inc. | 3.63 Million USD | -351.194% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.229% |
| PAVmed Inc | 33.11 Million USD | 50.521% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 88.577% |
| RxSight, Inc. | 182.55 Million USD | 91.023% |
| Sight Sciences, Inc. | 166.65 Million USD | 90.167% |
| SI-BONE, Inc. | 230.42 Million USD | 92.888% |
| TELA Bio, Inc. | 78.04 Million USD | 79.004% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 93.495% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -52.721% |
| Acutus Medical, Inc. | 53.96 Million USD | 69.631% |
| Talis Biomedical Corporation | 98.34 Million USD | 83.336% |
| Spectral AI, Inc. | 10.69 Million USD | -53.264% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 92.505% |
| CVRx, Inc. | 115.22 Million USD | 85.779% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 72.065% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -426.025% |
| Bioventus Inc. | 810.91 Million USD | 97.979% |
| Venus Concept Inc. | 93.65 Million USD | 82.503% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 36.299% |
| LivaNova PLC | 2.42 Billion USD | 99.326% |
| 908 Devices Inc. | 202.98 Million USD | 91.927% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 97.965% |
| Nemaura Medical Inc. | 14.56 Million USD | -12.523% |
| NeuroPace, Inc. | 107.65 Million USD | 84.778% |
| LENSAR, Inc. | 69.58 Million USD | 76.45% |
| Apyx Medical Corporation | 79.24 Million USD | 79.32% |
| Cutera, Inc. | 346.29 Million USD | 95.268% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 60.998% |
| BioSig Technologies, Inc. | 1.79 Million USD | -811.402% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 93.945% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 61.588% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.567% |
| Axonics, Inc. | 719.92 Million USD | 97.724% |
| Outset Medical, Inc. | 313.8 Million USD | 94.778% |
| IRIDEX Corporation | 34.43 Million USD | 52.413% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 95.951% |
| IRadimed Corporation | 92.15 Million USD | 82.218% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -211.896% |
| INVO Bioscience, Inc. | 20.88 Million USD | 21.547% |
| Telesis Bio, Inc. | 70.41 Million USD | 76.727% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 89.366% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.689% |
| Quipt Home Medical Corp. | 247.4 Million USD | 93.377% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -76.015% |
| Pulmonx Corporation | 178.95 Million USD | 90.843% |
| Dynatronics Corporation | 25.94 Million USD | 36.829% |
| Modular Medical, Inc. | 13.8 Million USD | -18.686% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -52.764% |
| Semler Scientific, Inc. | 78.06 Million USD | 79.009% |
| InMode Ltd. | 863.28 Million USD | 98.102% |
| Bruker Corporation | 4.24 Billion USD | 99.614% |
| Cytosorbents Corporation | 53.26 Million USD | 69.232% |
| DexCom, Inc. | 6.26 Billion USD | 99.738% |
| Align Technology, Inc. | 6.08 Billion USD | 99.731% |
| Viveve Medical, Inc. | 25.91 Million USD | 36.761% |
| ZimVie Inc. | 1.2 Billion USD | 98.64% |
| Movano Inc. | 9.42 Million USD | -73.941% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 96.707% |
| Nexalin Technology, Inc. | 3.63 Million USD | -351.194% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 72.065% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.28% |
| Profound Medical Corp. | 43.68 Million USD | 62.489% |
| Insulet Corporation | 2.58 Billion USD | 99.367% |
| enVVeno Medical Corporation | 48.63 Million USD | 66.306% |
| Surmodics, Inc. | 185.73 Million USD | 91.177% |
| iCAD, Inc. | 41.41 Million USD | 60.435% |
| Nuwellis, Inc. | 9.77 Million USD | -67.728% |
| Biotricity, Inc. | 5.94 Million USD | -175.754% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 96.217% |
| Aethlon Medical, Inc. | 8.24 Million USD | -98.727% |
| InspireMD, Inc. | 47.64 Million USD | 65.605% |
| PAVmed Inc. | 33.11 Million USD | 50.521% |
| BIOLASE, Inc. | 35.1 Million USD | 53.315% |
| Beyond Air, Inc. | 56.96 Million USD | 71.231% |
| FONAR Corporation | 214.24 Million USD | 92.351% |
| AxoGen, Inc. | 196.82 Million USD | 91.674% |
| Vivani Medical, Inc. | 45.79 Million USD | 64.218% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 94.177% |
| Inari Medical, Inc. | 674.23 Million USD | 97.57% |
| UFP Technologies, Inc. | 404.13 Million USD | 95.945% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 29.966% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -72.438% |
| Tenon Medical, Inc. | 6.34 Million USD | -158.266% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -74.2% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 84.19% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.645% |
| Sintx Technologies, Inc. | 15.36 Million USD | -6.651% |
| NanoVibronix, Inc. | 6.67 Million USD | -145.535% |
| Quanterix Corporation | 425.01 Million USD | 96.144% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -76.015% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 69.5% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.061% |
| TransMedics Group, Inc. | 706.04 Million USD | 97.679% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 74.068% |
| NeuroMetrix, Inc. | 21.42 Million USD | 23.513% |
| Hyperfine, Inc. | 94.19 Million USD | 82.604% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 93.9% |
| Biomerica, Inc. | 9.25 Million USD | -77.08% |
| Bone Biologics Corporation | 3.73 Million USD | -338.417% |
| AVITA Medical, Inc. | 144.33 Million USD | 88.647% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -236.59% |
| Silk Road Medical, Inc | 265.3 Million USD | 93.823% |